- Home
- VIR vs UWMC Comparison
VIR vs UWMC Comparison
Compare VIR & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- UWMC
- Stock Information
- Founded
- VIR 2016
- UWMC 1986
- Country
- VIR United States
- UWMC United States
- Employees
- VIR N/A
- UWMC N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- UWMC Finance: Consumer Services
- Sector
- VIR Health Care
- UWMC Finance
- Exchange
- VIR Nasdaq
- UWMC Nasdaq
- Market Cap
- VIR 706.4M
- UWMC 825.8M
- IPO Year
- VIR 2019
- UWMC N/A
- Fundamental
- Price
- VIR $5.23
- UWMC $4.20
- Analyst Decision
- VIR Strong Buy
- UWMC Hold
- Analyst Count
- VIR 8
- UWMC 8
- Target Price
- VIR $30.25
- UWMC $6.18
- AVG Volume (30 Days)
- VIR 1.2M
- UWMC 7.7M
- Earning Date
- VIR 07-31-2025
- UWMC 08-05-2025
- Dividend Yield
- VIR N/A
- UWMC 9.54%
- EPS Growth
- VIR N/A
- UWMC N/A
- EPS
- VIR N/A
- UWMC N/A
- Revenue
- VIR $20,861,000.00
- UWMC $2,486,541,000.00
- Revenue This Year
- VIR N/A
- UWMC $11.32
- Revenue Next Year
- VIR $0.62
- UWMC $22.84
- P/E Ratio
- VIR N/A
- UWMC N/A
- Revenue Growth
- VIR N/A
- UWMC 10.39
- 52 Week Low
- VIR $4.32
- UWMC $3.80
- 52 Week High
- VIR $14.45
- UWMC $9.74
- Technical
- Relative Strength Index (RSI)
- VIR 51.12
- UWMC 49.46
- Support Level
- VIR $5.20
- UWMC $4.03
- Resistance Level
- VIR $6.23
- UWMC $4.32
- Average True Range (ATR)
- VIR 0.29
- UWMC 0.15
- MACD
- VIR 0.03
- UWMC 0.01
- Stochastic Oscillator
- VIR 38.08
- UWMC 48.81
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.